CALML5 and neoplasm: Other targets included Filaggrin-2, peroxiredoxin 6, Calmodulin-like protein 5, TBCEL-TECTA readthrough protein, Desmocollin 1 and 3, and Desmoplakin variant protein—with implications in diagnosis and tumour progression [40].